Oruka Therapeutics announced that it will receive $275 million in a round of funding on April 3, 2024. The transaction included participation from syndicate of healthcare investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.83 USD | +6.39% | +9.43% | +125.29% |
04-25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | North American Morning Briefing : Stock Futures -2- | DJ |
1st Jan change | Capi. | |
---|---|---|
+125.29% | 55.56M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- ABIO Stock
- News ARCA biopharma, Inc.
- Oruka Therapeutics announced that it expects to receive $275 million in funding